Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1

Mol Cell Biol. 1995 Sep;15(9):4930-8. doi: 10.1128/MCB.15.9.4930.

Abstract

Inhibitors of protein synthesis, such as anisomycin and cycloheximide, lead to superinduction of immediate-early genes. We demonstrate that these two drugs activate intracellular signaling pathways involving both the mitogen-activated protein kinase (MAPK) and stress-activated protein kinase (SAPK) cascades. The activation of either pathway correlates with phosphorylation of the c-fos regulatory transcription factor Elk-1. In HeLa cells, anisomycin stabilizes c-fos mRNA when protein synthesis is inhibited to only 50%. Under these conditions, anisomycin, in contrast to cycloheximide, rapidly induces kinase activation and efficient Elk-1 phosphorylation. However, full inhibition of translation by either drug leads to prolonged activation of SAPK activity, while MAPK induction is transient. This correlates with prolonged Elk-1 phosphorylation and c-fos transcription. Elk-1 induction and c-fos activation are also observed in KB cells, in which anisomycin strongly induces SAPKs but not MAPKs. Purified p54 SAPK alpha efficiently phosphorylates the Elk-1 C-terminal domain in vitro and comigrates with anisomycin-activated kinases in in-gel kinase assays. Thus, Elk-1 provides a potential convergence point for the MAPK and SAPK signaling pathways. The activation of signal cascades and control of transcription factor function therefore represent prominent processes in immediate-early gene superinduction.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anisomycin / pharmacology
  • Blotting, Northern
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
  • Cycloheximide / pharmacology
  • DNA-Binding Proteins*
  • Dose-Response Relationship, Drug
  • Electrophoresis, Polyacrylamide Gel
  • Epidermal Growth Factor / pharmacology
  • Gene Expression Regulation, Enzymologic*
  • HeLa Cells
  • Humans
  • MAP Kinase Kinase 4*
  • Mitogen-Activated Protein Kinase Kinases*
  • Phosphorylation
  • Protein Kinases / metabolism*
  • Protein Synthesis Inhibitors / pharmacology*
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogene Proteins c-fos / genetics
  • RNA, Messenger / analysis
  • Signal Transduction / drug effects*
  • Transcription Factors*
  • ets-Domain Protein Elk-1

Substances

  • DNA-Binding Proteins
  • ELK1 protein, human
  • Protein Synthesis Inhibitors
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-fos
  • RNA, Messenger
  • Transcription Factors
  • ets-Domain Protein Elk-1
  • Epidermal Growth Factor
  • Anisomycin
  • Cycloheximide
  • Protein Kinases
  • Calcium-Calmodulin-Dependent Protein Kinases
  • MAP Kinase Kinase 4
  • MAP2K4 protein, human
  • Mitogen-Activated Protein Kinase Kinases